Hare K - Search Results

1

On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans.

Asmar M, Tangaa W, Madsbad S, Hare K, Astrup A, Flint A, Bülow J, Holst JJ. Asmar M, et al. Among authors: hare k. Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E614-21. doi: 10.1152/ajpendo.00639.2009. Epub 2009 Dec 8. Am J Physiol Endocrinol Metab. 2010. PMID: 19996386 Free article.

2

Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

Hartmann B, Thulesen J, Hare KJ, Kissow H, Orskov C, Poulsen SS, Holst JJ. Hartmann B, et al. Regul Pept. 2002 May 30;105(3):173-9. doi: 10.1016/s0167-0115(02)00013-7. Regul Pept. 2002. PMID: 11959371

3

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.

Thulesen J, Hartmann B, Hare KJ, Kissow H, Ørskov C, Holst JJ, Poulsen SS. Thulesen J, et al. Among authors: hare kj. Gut. 2004 Aug;53(8):1145-50. doi: 10.1136/gut.2003.035212. Gut. 2004. PMID: 15247183 Free PMC article.

4

GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.

Ørskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ. Ørskov C, et al. Regul Pept. 2005 Jan 15;124(1-3):105-12. doi: 10.1016/j.regpep.2004.07.009. Regul Pept. 2005. PMID: 15544847

5

Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY.

Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellström PM. Schmidt PT, et al. Eur J Gastroenterol Hepatol. 2005 Feb;17(2):207-12. doi: 10.1097/00042737-200502000-00012. Eur J Gastroenterol Hepatol. 2005. PMID: 15674099

6

Metabolism of glucagon-like peptide-2 in pigs: role of dipeptidyl peptidase IV.

Hansen L, Hare KJ, Hartmann B, Deacon CF, Ugleholdt RK, Plamboeck A, Holst JJ. Hansen L, et al. Among authors: hare kj. Regul Pept. 2007 Feb 1;138(2-3):126-32. doi: 10.1016/j.regpep.2006.08.012. Epub 2006 Nov 14. Regul Pept. 2007. PMID: 17107718

7

The intestinotrophic peptide, glp-2, counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, gefitinib.

Hare KJ, Hartmann B, Kissow H, Holst JJ, Poulsen SS. Hare KJ, et al. Clin Cancer Res. 2007 Sep 1;13(17):5170-5. doi: 10.1158/1078-0432.CCR-07-0574. Clin Cancer Res. 2007. PMID: 17785573

8

Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus.

Hare KJ, Knop FK, Asmar M, Madsbad S, Deacon CF, Holst JJ, Vilsbøll T. Hare KJ, et al. J Clin Endocrinol Metab. 2009 Dec;94(12):4679-87. doi: 10.1210/jc.2009-0921. Epub 2009 Oct 16. J Clin Endocrinol Metab. 2009. PMID: 19837930 Clinical Trial.

9

Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.

Asmar M, Højberg PV, Deacon CF, Hare K, Holst JJ, Madsbad S. Asmar M, et al. Among authors: hare k. Regul Pept. 2010 Feb 25;160(1-3):175-80. doi: 10.1016/j.regpep.2009.12.004. Epub 2010 Jan 13. Regul Pept. 2010. PMID: 20005261 Clinical Trial.

10

Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes.

Hare KJ, Vilsbøll T, Holst JJ, Knop FK. Hare KJ, et al. Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E832-7. doi: 10.1152/ajpendo.00700.2009. Epub 2010 Jan 26. Am J Physiol Endocrinol Metab. 2010. PMID: 20103744 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters